Comments
Loading...

LakeShore Biopharma

LSBNASDAQ
$0.480000
0.049.84%
At Close: -
$0.476300
-0.0037-0.77%
After Hours: 8:46 AM EDT
15 minutes delayed

LakeShore Biopharma (NASDAQ:LSB) Stock, Earnings Estimates, EPS, And Revenue

LakeShore Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Jul 30
EPS Estimate
$-0.090
Quarterly Revenue Estimate
$24.3M
Annual Revenue
(as of Sep 30)
$560.8M

Analyze the earnings history of LakeShore Biopharma using advanced sorting and filters.

Get Alert
LSB
LakeShore Biopharma
-$0.10-$0.09$19.60M$24.21M08/13/2024Get Alert
LSB
LakeShore Biopharma
-$0.09$24.25M07/30/2024Get Alert
LSB
LakeShore Biopharma
-$0.07-$0.12-71.43%$22.84M$23.82M4.27%04/19/2024Get Alert
LSB
LakeShore Biopharma
-$0.08-$0.16-100.00%$23.11M$13.64M-40.97%01/22/2024Get Alert
LSB
LakeShore Biopharma
-$0.10$19.60M08/15/2023Get Alert

LakeShore Biopharma (LSB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-04-19$-0.12$-0.07-71.4 %
Dec 20232024-01-22$-0.16$-0.08-100.0 %

LakeShore Biopharma (LSB) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Mar 20242024-04-19$23.82M$22.84M4.27 %
Dec 20232024-01-22$13.64M$23.11M-41.0 %

FAQ

Q

When is LakeShore Biopharma (NASDAQ:LSB) reporting earnings?

A

LakeShore Biopharma (LSB) is scheduled to report earnings on August 13, 2024. The last reported earnings were for reported on April 19, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for LakeShore Biopharma (NASDAQ:LSB)?

A

The Actual EPS was $-0.12, which missed the estimate of $-0.07.

Q

What were LakeShore Biopharma’s (NASDAQ:LSB) revenues?

A

The Actual Revenue was $23.8M, which beat the estimate of $22.8M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch